<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Baxter International Inc — News on 6ix</title>
<link>https://6ix.com/company/baxter-international-inc</link>
<description>Latest news and press releases for Baxter International Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 23 Apr 2026 09:49:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/baxter-international-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68354b1378dffbe2df0e4f1a.webp</url>
<title>Baxter International Inc</title>
<link>https://6ix.com/company/baxter-international-inc</link>
</image>
<item>
<title>Long-Term Care and Home Healthcare Global Market Analysis and Technology Research Report 2026-2030, Profiles of Leading Players - Baxter, Medtronic, Koninklijke Philips, ResMed, Sunrise Medical</title>
<link>https://6ix.com/company/baxter-international-inc/news/long-term-care-and-home-healthcare-global-market-analysis-and-technology-research-report-2026-2030-profiles-of-leading-players-baxter-medtronic-koninklijke-philips-resmed-sunrise-medical</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/long-term-care-and-home-healthcare-global-market-analysis-and-technology-research-report-2026-2030-profiles-of-leading-players-baxter-medtronic-koninklijke-philips-resmed-sunrise-medical</guid>
<pubDate>Thu, 23 Apr 2026 09:49:00 GMT</pubDate>
<description>The aging population and prevalence of chronic diseases drive opportunities in long-term care and home healthcare technologies. Key growth areas include assistive living, rehabilitation, remote care, and monitoring. Regions like North America and Asia-Pacific present significant demand, with sustainability and ESG factors influencing advancements. Technologies for Long-Term Care and Home Healthcare Market Technologies for Long-Term Care and Home Healthcare Market Dublin, April 23, 2026 (GLOBE NE</description>
</item>
<item>
<title>Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-introduces-the-iv-verify-line-labeling-system-an-automated-solution-to-improve-iv-labeling-in-healthcare-settings</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-introduces-the-iv-verify-line-labeling-system-an-automated-solution-to-improve-iv-labeling-in-healthcare-settings</guid>
<pubDate>Mon, 30 Mar 2026 12:30:00 GMT</pubDate>
<description>DEERFIELD, Ill., March 30, 2026--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and platforms, today debuted the IV Verify Line Labeling System, an automated solution, at the 2026 American Organization for Nursing Leadership Conference. The IV Verify system is designed to streamline nursing workflows, save clinician time and support safer medication administration at the bedside. Baxter’s launch of the product is the result of a strategic and exclusive distribut</description>
</item>
<item>
<title>Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot</title>
<link>https://6ix.com/company/baxter-international-inc/news/pet-partners-and-the-baxter-foundation-expand-therapy-animal-programs-to-support-100000-patients-and-healthcare-workers-in-two-year-pilot</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/pet-partners-and-the-baxter-foundation-expand-therapy-animal-programs-to-support-100000-patients-and-healthcare-workers-in-two-year-pilot</guid>
<pubDate>Wed, 25 Mar 2026 13:00:00 GMT</pubDate>
<description>Pet Partners, the nation's leading organization dedicated to improving human health and well-being through therapy animal interactions, and the Baxter Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced a new partnership to expand access to therapy animal programs in healthcare settings across the country. The initiative will begin as a two-year pilot program in key regions, including Northern California, Upstate New York and Greate</description>
</item>
<item>
<title>Baxter Announces CFO Transition</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-announces-cfo-transition</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-announces-cfo-transition</guid>
<pubDate>Mon, 16 Mar 2026 12:45:00 GMT</pubDate>
<description>DEERFIELD, Ill., March 16, 2026--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the departure of executive vice president and chief financial officer (CFO) Joel Grade. Mr. Grade is leaving the company to prioritize family matters but will continue in an advisory capacity until April 30, 2026.</description>
</item>
<item>
<title>Myxredlin (Baxter International) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F</title>
<link>https://6ix.com/company/baxter-international-inc/news/myxredlin-baxter-international-market-research-report-2026-epidemiology-pipeline-analysis-trends-strategies-and-forecasts-2020-2025-2025-2030f-2035f</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/myxredlin-baxter-international-market-research-report-2026-epidemiology-pipeline-analysis-trends-strategies-and-forecasts-2020-2025-2025-2030f-2035f</guid>
<pubDate>Fri, 13 Mar 2026 11:37:00 GMT</pubDate>
<description>Key market opportunities for Myxredlin include increasing hospitalization and critical care needs due to rising diabetes prevalence, expanding intensive care units, and adoption of rapid glycemic control protocols. Aging populations and tariff impacts drive a shift to localized insulin manufacturing and supply chain resilience.Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Myxredlin Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMa</description>
</item>
<item>
<title>Baxter Reports Fourth-Quarter 2025 Results</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-reports-fourth-quarter-2025-121500653</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-reports-fourth-quarter-2025-121500653</guid>
<pubDate>Thu, 12 Feb 2026 12:15:00 GMT</pubDate>
<description>DEERFIELD, Ill., February 12, 2026--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter of 2025.</description>
</item>
<item>
<title>Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-host-fourth-quarter-2025-220000903</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-host-fourth-quarter-2025-220000903</guid>
<pubDate>Wed, 21 Jan 2026 22:00:00 GMT</pubDate>
<description>DEERFIELD, Ill., January 21, 2026--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its fourth-quarter 2025 financial results on Thursday, February 12, 2026 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I81994118 to pre-register for the call and receive the call information.</description>
</item>
<item>
<title>Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-introduces-dynamo-series-smart-140000314</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-introduces-dynamo-series-smart-140000314</guid>
<pubDate>Tue, 13 Jan 2026 14:00:00 GMT</pubDate>
<description>DEERFIELD, Ill., January 13, 2026--BAXTER INTRODUCES THE DYNAMO SERIES, A NEW SMART STRETCHER TO HELP ADDRESS COMMON CHALLENGES IN HOSPITAL SETTINGS</description>
</item>
<item>
<title>MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges</title>
<link>https://6ix.com/company/baxter-international-inc/news/musc-health-and-baxter-announce-strategic-partnership-to-transform-bedside-care-delivery-and-address-critical-nursing-challenges</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/musc-health-and-baxter-announce-strategic-partnership-to-transform-bedside-care-delivery-and-address-critical-nursing-challenges</guid>
<pubDate>Thu, 08 Jan 2026 14:00:00 GMT</pubDate>
<description>CHARLESTON, S.C., January 08, 2026--MUSC Health and Baxter International Inc. (NYSE:BAX), a global medtech leader, are entering into a multi-year strategic partnership that aims to enhance the high-quality and safe patient care already delivered at MUSC Health, MUSC’s health care system, through integrated connected care technologies.</description>
</item>
<item>
<title>Baxter to Present at J.P. Morgan 2026 Healthcare Conference</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-present-j-p-morgan-221400144</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-present-j-p-morgan-221400144</guid>
<pubDate>Tue, 06 Jan 2026 22:14:00 GMT</pubDate>
<description>DEERFIELD, Ill., January 06, 2026--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026. Andrew Hider, Baxter’s president and chief executive officer, is scheduled to present at 2:15 p.m. Pacific Time.</description>
</item>
<item>
<title>Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-presents-real-world-data-133000784</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-presents-real-world-data-133000784</guid>
<pubDate>Thu, 11 Dec 2025 13:30:00 GMT</pubDate>
<description>DEERFIELD, Ill., December 11, 2025--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas Medical Branch (UTMB Health) demonstrating the positive impact of smart infusion pump integration with hospital electronic medical records (EMRs) on patient safety, clinicians' bedside productivity and programming compliance. The analyses of more than one million infusions on Baxter’s Spectrum IQ</description>
</item>
<item>
<title>Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-announces-pricing-tender-offers-211500651</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-announces-pricing-tender-offers-211500651</guid>
<pubDate>Thu, 04 Dec 2025 21:15:00 GMT</pubDate>
<description>DEERFIELD, Ill., December 04, 2025--Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced the consideration payable in connection with the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The table below sets forth the Total Consideration (as defined below) for each series of Notes.</description>
</item>
<item>
<title>Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-announces-early-tender-results-125100926</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-announces-early-tender-results-125100926</guid>
<pubDate>Thu, 04 Dec 2025 12:51:00 GMT</pubDate>
<description>DEERFIELD, Ill., December 04, 2025--Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced the early tender results for the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The tender offers are being made pursuant to the terms and conditions set forth in the offer to purchase, dated Nov. 19, 2025, as amended by the Company’s press release dated Nov. 19, 2025 (as it may be further amended or supplemented from time to tim</description>
</item>
<item>
<title>Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-announces-increase-maximum-tender-211500675</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-announces-increase-maximum-tender-211500675</guid>
<pubDate>Wed, 19 Nov 2025 21:15:00 GMT</pubDate>
<description>DEERFIELD, Ill., November 19, 2025--Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced that it has increased the maximum purchase price for its $1.45 billion aggregate principal amount outstanding of 1.915% Senior Unsecured Notes due 2027 (the "2027 Notes") that it can repurchase under its previously announced cash tender offer for the 2027 Notes (the "2027 Notes Tender Offer") from $300 million to $600 million, on the terms and subject to the conditions set forth i</description>
</item>
<item>
<title>Baxter Announces Tender Offers for 2026 Notes and 2027 Notes</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-announces-tender-offers-2026-135400818</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-announces-tender-offers-2026-135400818</guid>
<pubDate>Wed, 19 Nov 2025 13:54:00 GMT</pubDate>
<description>DEERFIELD, Ill., November 19, 2025--Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced the commencement of tender offers, subject to the terms and conditions described below, to purchase for cash the debt securities issued by Baxter listed in the table below (collectively, the "Securities" and each a "series"). Subject to market conditions, the tender offers are expected to be funded using a portion of the proceeds from a concurrent offering of senior unsecured note</description>
</item>
<item>
<title>Baxter Declares Quarterly Dividend</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-declares-quarterly-dividend-213000959</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-declares-quarterly-dividend-213000959</guid>
<pubDate>Tue, 11 Nov 2025 21:30:00 GMT</pubDate>
<description>DEERFIELD, Ill., November 11, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.01 per share of common stock. The dividend is payable on Jan. 2, 2026, to stockholders of record as of Nov. 28, 2025. The indicated annual dividend rate equates to $0.04 per share of common stock.</description>
</item>
<item>
<title>The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-foundation-announces-2-6m-134500902</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-foundation-announces-2-6m-134500902</guid>
<pubDate>Fri, 07 Nov 2025 13:45:00 GMT</pubDate>
<description>DEERFIELD, Ill., November 07, 2025--The Baxter Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the continuation of a partnership with Northwestern University’s School of Education and Social Policy (SESP) to provide science, technology, engineering and math (STEM) programs for students and teachers throughout the Chicagoland area. Supported by a three-year $2.6 million grant from the Foundation, the Baxter Center for Science Edu</description>
</item>
<item>
<title>Baxter Reports Third-Quarter 2025 Results</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-reports-third-quarter-2025-111500117</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-reports-third-quarter-2025-111500117</guid>
<pubDate>Thu, 30 Oct 2025 11:15:00 GMT</pubDate>
<description>DEERFIELD, Ill., October 30, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2025.</description>
</item>
<item>
<title>Baxter to Host Third-Quarter 2025 Financial Results Conference Call for Investors</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-host-third-quarter-2025-201500622</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-host-third-quarter-2025-201500622</guid>
<pubDate>Wed, 15 Oct 2025 20:15:00 GMT</pubDate>
<description>DEERFIELD, Ill., October 15, 2025--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its third-quarter 2025 financial results on Thursday, October 30, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156235 to pre-register for the call and receive the call information.</description>
</item>
<item>
<title>Baxter is First Manufacturer to Achieve Gold Resiliency Badge for IV Solutions, Nutrition Solutions and Premix Drugs from Healthcare Industry Resilience Collaborative (HIRC)</title>
<link>https://6ix.com/company/baxter-international-inc/news/baxter-first-manufacturer-achieve-gold-123000361</link>
<guid isPermaLink="true">https://6ix.com/company/baxter-international-inc/news/baxter-first-manufacturer-achieve-gold-123000361</guid>
<pubDate>Fri, 26 Sep 2025 12:30:00 GMT</pubDate>
<description>DEERFIELD, Ill., September 26, 2025--Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has been awarded a Gold Level Resiliency Badge from the Healthcare Industry Resilience Collaborative (HIRC) in the categories of IV Solutions, Nutrition Solutions and Premix Drugs. Baxter is the first manufacturer to earn this distinction across these categories, underscoring Baxter’s commitment to building a stronger, more reliable supply chain.</description>
</item>
</channel>
</rss>